Department of Cardiology, Istanbul Bilim University, Florence Nightingale Hospital, Istanbul, Turkey.
Department of Cardiology, Koc University Hospital, Istanbul, Turkey.
Rev Port Cardiol (Engl Ed). 2020 Oct;39(10):565-572. doi: 10.1016/j.repc.2020.06.014. Epub 2020 Sep 30.
The prognosis of chronic heart failure with reduced ejection fraction (HFrEF) has been studied extensively, but factors predicting cardiac decompensation are poorly defined. Right ventricular stroke work index (RVSWI), an invasive measure of right ventricular (RV) systolic function, is a well-known prognostic marker of RV failure after left ventricular assist device insertion and after lung transplantation. Thus, the aim of this study was to assess whether there is a relationship between RVSWI, HFrEF hospital readmission due to cardiac decompensation, and prognosis.
We prospectively enrolled 132 consecutive patients with HFrEF. Right heart catheterization was performed and RVSWI values were calculated in all patients. The relationship between RVSWI values and readmission and prognosis was analyzed.
During a median follow-up of 20±7 months, 33 patients were readmitted due to cardiac decompensation in the survivor group, and 18 patients died due to cardiac causes. There was no difference between patients who died and survived in terms of RVSWI values. Among patients with decompensation, mean RVSWI was significantly lower than in patients with stable HFrEF (6.0±2.2 g/m/beat vs. 8.8±3.5 g/m/beat, p<0.001). On correlation analysis, RVSWI was negatively correlated with NYHA functional class. RVSWI was also identified as an independent risk factor for cardiac decompensation in Cox regression survival analysis.
We showed that RVSWI predicts cardiac decompensation and correlates with functional class in advanced stage HFrEF. Our data suggest the value of combining information on right heart hemodynamics with assessment of RV function when defining the risk of patients with advanced HFrEF.
射血分数降低的慢性心力衰竭(HFrEF)的预后已经得到了广泛研究,但预测心脏失代偿的因素仍定义不清。右心室每搏功指数(RVSWI)是一种侵入性的右心室(RV)收缩功能指标,它是左心室辅助装置植入和肺移植后 RV 衰竭的一个很好的预后标志物。因此,本研究旨在评估 RVSWI 与因心脏失代偿而导致的 HFrEF 住院再入院之间是否存在关系,以及与预后之间是否存在关系。
我们前瞻性地纳入了 132 例连续的 HFrEF 患者。所有患者均进行了右心导管检查,并计算了 RVSWI 值。分析了 RVSWI 值与再入院和预后的关系。
在中位数为 20±7 个月的随访期间,33 例存活患者因心脏失代偿而再次入院,18 例患者因心脏原因死亡。死亡患者与存活患者的 RVSWI 值无差异。在失代偿患者中,平均 RVSWI 明显低于稳定的 HFrEF 患者(6.0±2.2 g/m/beat vs. 8.8±3.5 g/m/beat,p<0.001)。相关性分析显示,RVSWI 与 NYHA 功能分级呈负相关。在 Cox 回归生存分析中,RVSWI 也是心脏失代偿的独立危险因素。
我们表明 RVSWI 可预测心脏失代偿,并与晚期 HFrEF 患者的功能分级相关。我们的数据表明,在定义晚期 HFrEF 患者的风险时,将右心血流动力学信息与 RV 功能评估相结合具有价值。